<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="retraction" xmlns:xlink="http://www.w3.org/1999/xlink">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IJO</journal-id>
<journal-title-group>
<journal-title>International Journal of Oncology</journal-title></journal-title-group>
<issn pub-type="ppub">1019-6439</issn>
<issn pub-type="epub">1791-2423</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/ijo.2016.3737</article-id>
<article-id pub-id-type="publisher-id">ijo-50-01-0337</article-id>
<article-categories>
<subj-group>
<subject>Retraction</subject></subj-group></article-categories>
<title-group>
<article-title>Epidermal growth factor-stimulated human cervical cancer cell growth is associated with EGFR and cyclin D1 activation, independent of COX-2 expression levels</article-title></title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Narayanan</surname><given-names>Rajkishen</given-names></name></contrib>
<contrib contrib-type="author">
<name><surname>Kim</surname><given-names>Hye Na</given-names></name></contrib>
<contrib contrib-type="author">
<name><surname>Narayanan</surname><given-names>Narayanan K.</given-names></name></contrib>
<contrib contrib-type="author">
<name><surname>Nargi</surname><given-names>Dominick</given-names></name></contrib>
<contrib contrib-type="author">
<name><surname>Narayanan</surname><given-names>Bhagavathi</given-names></name></contrib></contrib-group>
<pub-date pub-type="collection">
<month>01</month>
<year>2017</year></pub-date>
<pub-date pub-type="epub">
<day>18</day>
<month>10</month>
<year>2016</year></pub-date>
<volume>50</volume>
<issue>1</issue>
<fpage>337</fpage>
<lpage>337</lpage>
<permissions>
<copyright-statement>Copyright: &#x000A9; Narayanan et al.</copyright-statement>
<copyright-year>2017</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-NonCommercial-NoDerivs License</ext-link>, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.</license-p></license></permissions></article-meta></front>
<body>
<p>Int J Oncol 40: <related-article id="RA1" related-article-type="retracted-article" vol="40" page="13" ext-link-type="doi" xlink:href="10.3892/ijo.2011.1211">13&#x02013;20</related-article>, 2012</p>
<p>Following the publication of this article, which was concerned with the expression of phosphorylated epidermal growth factor receptor (pEGFR) and cyclin D1 activation independently of the expression levels of cyclo-oxygenase-2, an interested reader drew to our attention apparent anomalies associated with the western blot data shown in Fig. 2C. Following an internal investigation at the New York University School of Medicine, we were requested to produce the original film, or the scan of the image of the film, for verification. Unfortunately, we were unable to provide the original film or scanned image to disprove the allegation, since the original pEGFR image could not be found. Therefore, the Investigation Committee recommended that this article be retracted, and we are withdrawing the article in line with the request. All the authors agree to the retraction of this paper. We sincerely regret any inconvenience this has caused.</p></body></article>
